First Time Loading...

OptiBiotix Health PLC
LSE:OPTI

Watchlist Manager
OptiBiotix Health PLC Logo
OptiBiotix Health PLC
LSE:OPTI
Watchlist
Price: 19.6 GBX -6.67%
Updated: Mar 29, 2024

Intrinsic Value

OPTI doesn't have a meaningful market cap.

Optibiotix Health Plc is engaged in the research and development of compounds that modify the human microbiome. [ Read More ]

The intrinsic value of one OPTI stock under the Base Case scenario is 11.33 GBX. Compared to the current market price of 19.6 GBX, OptiBiotix Health PLC is Overvalued by 42%.

Key Points:
OPTI Intrinsic Value
Base Case
11.33 GBX
Overvaluation 42%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
OptiBiotix Health PLC

Backtest OPTI Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OPTI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of OptiBiotix Health PLC's business.

What risks and challenges
does OptiBiotix Health PLC face in the near future?

Summarize the latest earnings report
of OptiBiotix Health PLC.

Provide P/E
for OptiBiotix Health PLC and its competitors.

Financials

Balance Sheet Decomposition
OptiBiotix Health PLC

Current Assets 1.8m
Cash & Short-Term Investments 893k
Receivables 772k
Other Current Assets 179k
Non-Current Assets 8.1m
Long-Term Investments 6.6m
Intangibles 1.5m
Current Liabilities 514k
Accounts Payable 514k
Non-Current Liabilities 348k
Other Non-Current Liabilities 348k
Efficiency

Earnings Waterfall
OptiBiotix Health PLC

Revenue
689.1k GBP
Cost of Revenue
-349.3k GBP
Gross Profit
339.8k GBP
Operating Expenses
11.1m GBP
Operating Income
11.4m GBP
Other Expenses
-24.6m GBP
Net Income
-13.2m GBP

Free Cash Flow Analysis
OptiBiotix Health PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

OPTI Profitability Score
Profitability Due Diligence

OptiBiotix Health PLC's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Positive Operating Income
Negative Net Income
51/100
Profitability
Score

OptiBiotix Health PLC's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

OPTI Solvency Score
Solvency Due Diligence

OptiBiotix Health PLC's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

OptiBiotix Health PLC's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OPTI Price Targets Summary
OptiBiotix Health PLC

There are no price targets for OPTI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

OPTI Price
OptiBiotix Health PLC

1M 1M
-27%
6M 6M
-30%
1Y 1Y
+91%
3Y 3Y
-64%
5Y 5Y
-76%
10Y 10Y
+118%
Annual Price Range
19.6
52w Low
6
52w High
39
Price Metrics
Average Annual Return -29.78%
Standard Deviation of Annual Returns 29.01%
Max Drawdown -93%
Shares Statistics
Market Capitalization 17.3m GBX
Shares Outstanding 91 190 700
Percentage of Shares Shorted
N/A

OPTI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

OptiBiotix Health PLC Logo
OptiBiotix Health PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

17.3m GBP

Dividend Yield

0%

Description

Optibiotix Health Plc is engaged in the research and development of compounds that modify the human microbiome. is a life sciences company. The firm is primarily engaged in identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry segment. The Company’s technology platforms include OptiBiome, OptiScreen and OptiBiotic. Its OptiBiome technology platform that screens identifies and/or develops microbiome modulators, which can be used in formulations to prevent, manage and a range of chronic lifestyle diseases. The Company’s OptiScreen pharmaceutical screening platform to identify microbial metabolic pathways that interact with human pathways to improve health. Its OptiBiotic platform generates oligosaccharides and screens them for their ability to modulate specific microbial genera or species and their microbial end products (short chain fatty acids, such as acetate, propionate, butyrate) and physical properties (sweetness). Its products include SlimBiome, SweetBiotix, CholBiome, SlimBiome Medical and WellBiome.

Contact

Heslington
Innovation Centre, Innovation Way
+442079338780.0
http://www.optibiotix.com/

IPO

2011-09-09

Employees

8

Officers

Founder, CEO & Executive Director
Mr. Stephen Patrick O'Hara
Executive Director of Research & Development and Executive Director
Dr. Sofia Kolyda
CFO & Secretary
Mr. Mark Kingsley Collingbourne
Head of Operations & Quality
Paul Cannings
Corporate Development Director
Kevin James Newman
Marketing Director
Mr. Karl Burkitt

See Also

Discover More
What is the Intrinsic Value of one OPTI stock?

The intrinsic value of one OPTI stock under the Base Case scenario is 11.33 GBX.

Is OPTI stock undervalued or overvalued?

Compared to the current market price of 19.6 GBX, OptiBiotix Health PLC is Overvalued by 42%.